| Our results indicate FOXD3 exhibits tumor suppressive activity and may be useful for breast therapy. | breast, |
| FOXD3 is a tumor suppressor of colon cancer by inhibiting EGFR-Ras-Raf-MEK-ERK signal pathway | colorectal, |
| Results indicate that FOXD3 exhibits tumor suppressive activity that affects the growth, aggressiveness and angiogenesis of NB through transcriptional regulation of NDRG1. | None |